VTE (VENOUS THROMBOEMBOLISM)
Clinical trials for VTE (VENOUS THROMBOEMBOLISM) explained in plain language.
Never miss a new study
Get alerted when new VTE (VENOUS THROMBOEMBOLISM) trials appear
Sign up with your email to follow new studies for VTE (VENOUS THROMBOEMBOLISM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which blood thinner works best after weight loss surgery? new study aims to find out
Disease control Not yet recruitingThis study compares two blood-thinning injections (tinzaparin and enoxaparin) to prevent dangerous blood clots after weight loss surgery. About 180 adults having laparoscopic sleeve gastrectomy or gastric bypass will be randomly assigned to one of the two drugs for 21 days after …
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: NA • Sponsor: University College Dublin • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New strategy aims to tame treatment side effects in lung cancer patients
Symptom relief Not yet recruitingThis study tests a special care plan to help Chinese patients with advanced EGFR-mutated lung cancer who are taking the drug amivantamab. The plan focuses on preventing common side effects like blood clots, skin rashes, and infusion reactions. About 122 adults will join to see if…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Blood clots after severe limb injuries may predict chronic pain
Knowledge-focused Not yet recruitingThis study follows 150 adults with severe arm or leg injuries to see if developing a blood clot raises the risk of long-term pain. Participants are enrolled within 72 hours of hospital admission and monitored for six months. The goal is to understand how blood clots and pain are …
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Sponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC